SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM 10-QSB



QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE



SECURITIES EXCHANGE ACT OF 1934



FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2007



Commission File #2-89616



CONSOLIDATED MEDICAL MANAGEMENT, INC.

(Exact name of registrant as specified in its charter)



MONTANA

(State or other jurisdiction of incorporation or organization)



82-0369233

(IRS Employer Identification Number)



2500 City West Boulevard, Suite 300, Houston, TX 77042

(Address of principal executive offices)



(281)209-9800

(Registrant's telephone no., including area code)



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]



Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [ ]  No [X]



State the number of shares outstanding of each of the issuers classes of common equity, as of the latest practicable date:



Title of Class

Number of Shares Outstanding

as of May 16, 2007



Common Stock,

par value $.001 per share

49,544,226



Transitional Small Business Disclosure Format (Check one): Yes [] No [X]



ITEM 1. FINANCIAL STATEMENTS.





---

CONSOLIDATED MEDICAL MANAGEMENT, INC.

(A MONTANA CORPORATION)



Consolidated Balance Sheet

AS OF MARCH 31, 2007 AND DECEMBER 31, 2006



|                                                                                                                             |                |  |                  | 
|---------------------------------------------------------------------------------------------------------------------------- | -------------- |  | ---------------- | 
|                                                                                                                             | March 31 2007  |  | December 31
2006
|ASSETS                                                                                                                       |                |  |                 
|Cash in bank                                                                                                                 | $       64,553 |  | $         14,223
|Accounts receivable, net of allowances                                                                                       | 123,565        |  | 137,945         
|Inventory                                                                                                                    | 31,230         |  | 0               
|Total current assets                                                                                                         | 219,348        |  | 152,168         
|                                                                                                                             |                |  |                 
|Equipment, net of depreciation of  $5,735 and $654,226                                                                       | 99,492         |  | 2,872,473       
|Land                                                                                                                         | 0              |  | 300,000         
|Investment in subsidiary                                                                                                     | 1,500,000      |  | 1,500,000       
|Intangible assets, net of amortization                                                                                       | 10,217         |  | 11,920          
|Notes and interest receivable                                                                                                | 1,005,208      |  | 1,091,813       
|Total non-current assets                                                                                                     | 2,614,917      |  | 5,776,206       
|                                                                                                                             |                |  |                 
|TOTAL ASSETS                                                                                                                 | $  2,834,265   |  | $    5,928,374  
|                                                                                                                             |                |  |                 
|LIABILITIES AND SHAREHOLDERS DEFICIT                                                                                        |                |  |                 
|Accounts payable and accrued liabilities                                                                                     | $   2,165,846  |  | $    1,691,300  
|Current portion of notes payable, including accrued interest of $98,333 and $60,833                                          | 489,603        |  | 1,941,016       
|Debenture payable                                                                                                            | 0              |  | 2,350,000       
|Outstanding stock options                                                                                                    | 37,500         |  | 37,500          
|Other payables                                                                                                               | 40,250         |  | 38,278          
|Total current liabilities                                                                                                    | 2,733,199      |  | 6,058,094       
|                                                                                                                             |                |  |                 
|Notes payable                                                                                                                | 1,500,000      |  | 1,500,000       
|                                                                                                                             |                |  |                 
|TOTAL LIABILITIES                                                                                                            | 4,233,199      |  | 7,558,094       
|                                                                                                                             |                |  |                 
|SHAREHOLDERS (DEFICIT)/EQUITY                                                                                               |                |  |                 
|Preferred stock, $.001 par value, 20,000,000 shares authorized, no shares outstanding                                        | 0              |  | 0               
|Capital stock, $0.001 par value, 50 million shares authorized, 44,544,226 shares issued and outstanding at December 31, 2006 | 44,544         |  | 44,544          
|Additional paid in capital                                                                                                   | 4,332,172      |  | 4,332,172       
|Deficit from operation                                                                                                       | (5,775,650)    |  | (6,006,436)     
|Total shareholders deficit                                                                                                  | (1,398,934)    |  | (1,629,720)     
|                                                                                                                             |                |  |                 
|TOTAL LIABILITIES AND SHAREHOLDERS DEFICIT                                                                                  | $   2,834,265  |  | $    5,928,374  





See accompanying notes to financial statements













---





CONSOLIDATED MEDICAL MANAGEMENT, INC.

(A MONTANA CORPORATION)



Consolidated Statement of Operations

FOR THE QUARTERS ENDED MARCH 31, 2007 AND 2006



|                                                                                                 |                              |  |                             
|------------------------------------------------------------------------------------------------ | ---------------------------- |  | ----------------------------
|                                                                                                 | Quarter Ended March 31, 2007 |  | Quarter Ended March 31, 2006
|REVENUES AND GROSS MARGINS                                                                       |                              |  |                             
|Revenues                                                                                         | 225,676                      |  | -0-                         
|Cost of product sales                                                                            | 34,339                       |  | -0-                         
|Gross margin on sales                                                                            | 191,337                      |  | -0-                         
|                                                                                                 |                              |  |                             
|OPERATING EXPENSES                                                                               |                              |  |                             
|Payroll and related expenses                                                                     | 25,559                       |  | -0-                         
|Terminal management                                                                              | 22,500                       |  |                             
|General and administrative                                                                       | 53,083                       |  | -0-                         
|Legal and professional                                                                           | 266,015                      |  | -0-                         
|Consulting fees                                                                                  | 107,000                      |  | 57,000                      
|Repairs                                                                                          | 7,122                        |  |                             
|Amortization of intangible assets                                                                | 1,703                        |  |                             
|Depreciation expense                                                                             | 114,428                      |  |                             
|Operating supplies                                                                               | 2,889                        |  |                             
|Total operating expenses                                                                         | 600,299                      |  | 57,000                      
|                                                                                                 |                              |  |                             
|OPERATING LOSS                                                                                   | (408,962)                    |  | (57,000)                    
|                                                                                                 |                              |  |                             
|OTHER INCOME AND EXPENSES                                                                        |                              |  |                             
|Interest income                                                                                  | 18,775                       |  |                             
|Interest expense                                                                                 | (38,841)                     |  |                             
|Gain from lawsuit                                                                                | 659,814                      |  |                             
|Total other income and expense                                                                   | 639,748                      |  |                             
|                                                                                                 |                              |  |                             
|NET INCOME/(LOSS)                                                                                | 230,786                      |  | (57,000)                    
|                                                                                                 |                              |  |                             
|Net loss per share, basic                                                                        | 0.005                        |  | (0.001)                     
|                                                                                                 |                              |  |                             
|Net loss per share, fully diluted (50,000,000 shares 2006 and 44,544,226 shares 2005) See Note 8 | 0.005                        |  | (0.001)                     
|                                                                                                 |                              |  |                             
|Weighted average shares outstanding                                                              | 44,544,226                   |  | 44,544,226                  





























---

CONSOLIDATED MEDICAL MANAGEMENT, INC.

(A MONTANA CORPORATION)



Consolidated Statement of Changes in Stockholders Equity (Deficit)

FOR THE QUARTER ENDED MARCH 31, 2007







|                           |            |  |         |  |                            |  |                          |  |                             |  |             
|-------------------------- | ---------- |  | ------- |  | -------------------------- |  | ------------------------ |  | --------------------------- |  | ------------
|                           | Shares     |  | Amount  |  | Additional Paid in Capital |  | Subscription

Receivable |  | Retained Earnings (Deficit) |  | Total       
|                           |            |  |         |  |                            |  |                          |  |                             |  |             
|Balance December 31, 2006  | 44,544,226 |  | $44,544 |  | $4,332,172                 |  | -0-                      |  | $(6,006,436)                |  | $(1,629,720)
|Shares issued for services |            |  |         |  |                            |  | -0-                      |  | -0-                         |  | -0-         
|Net income                 |            |  |         |  |                            |  |                          |  | 230,786                     |  | 230,786     
|Balance December 31, 2006  | 44,544,226 |  | $44,544 |  | $4,332,172                 |  | -0-                      |  | $(5,775,650)                |  | $(1,398,934)







---





CONSOLIDATED MEDICAL MANAGEMENT, INC.

(A MONTANA CORPORATION)



Consolidated Statement of Cash Flows

FOR THE YEARS ENDED MARCH 31, 2007 AND 2006



|                                                                                         |             |  |         
|---------------------------------------------------------------------------------------- | ----------- |  | --------
|                                                                                         | 2007        |  | 2006    
|Cash Flows from Operating Activities:                                                    |             |  |         
|Net Income                                                                               | 230,786     |  | (57,000)
|Adjustments to Reconcile net income (loss) to net cash provided by operating activities: |             |  |         
|Depreciation and amortization                                                            | 116,131     |  |         
|Change in operating assets and liabilities                                               |             |  |         
|Accounts receivable                                                                      | 14,380      |  |         
|Inventory                                                                                | (31,230)    |  |         
|Accounts payable and accrued liabilities                                                 | 476,518     |  |         
|Gain on disposition of assets from lawsuit settlement                                    | 659,814     |  |         
|                                                                                         |             |  |         
|Net cash used in operating activities                                                    | 1,466,399   |  | (57,000)
|                                                                                         |             |  |         
|CASH FLOWS FROM INVESTING ACTIVITIES                                                     |             |  |         
|Purchases of equipment                                                                   | (101,893)   |  |         
|Disposal of equipment                                                                    | 2,400,632   |  |         
|Notes receivable                                                                         | 86,605      |  |         
|                                                                                         |             |  |         
|Net cash provided from or (used in) investing activities                                 | 2,385,344   |  | -0-     
|                                                                                         |             |  |         
|CASH FLOWS FROM FINANCING ACTIVITIES:                                                    |             |  |         
|Retirement of notes payable                                                              | (3,801,413) |  |         
|Net cash provided from financing activities                                              | (3,801,413) |  | -0-     
|                                                                                         |             |  |         
|Net change in cash and cash equivalents                                                  | 50,330      |  | -0-     
|Cash and cash equivalents, beginning of period                                           | 14,223      |  | -0-     
|Cash and cash equivalents, end of period                                                 | 64,553      |  | -0-     
|                                                                                         |             |  |         



---



| |  |  | 
| |  |  | 





---

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(A) PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include all of the assets, liabilities and results of operations of subsidiaries in which the Company has a controlling interest. All significant inter-company accounts and transactions among consolidated entities have been eliminated.

(B) PROPERTY, EQUIPMENT AND DEPRECIATION

Expenditures for property, plant and equipment are recorded at cost. Renewals and improvements, which extend the economic life of such assets, are capitalized. Expenditures for maintenance, repairs and other renewals are charged to expense. For major dispositions, the cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the results of operations.

(C) CASH FLOWS AND CONCENTRATION OF CREDIT RISK

Cash consists principally of demand deposits at commercial banks. These balances, as reflected in the bank's records, are insured by the Federal Deposit Insurance Corporation up to $100,000. At March 31, 2007 and December 31, 2006, the Company's deposits did not exceed the insured limits.

(D) RISKS AND UNCERTAINTIES

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.

(E) EARNINGS PER COMMON SHARE

Basic earnings per share are computed on the basis of the weighted average number of common shares outstanding each year.

Diluted earnings per share are computed on the basis of the weighted average number of common shares and dilutive securities outstanding.

Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

(F) FAIR VALUE OF FINANCIAL INSTRUMENTS

The carrying value of financial instruments including marketable securities, notes and loans receivables, accounts payable and notes payable approximate their fair values at March 31, 2007 and December 31, 2006.

(G) LONG-LIVED ASSETS

Long lived assets include property and equipment and intangible assets to be held and used. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount should be addressed pursuant to SFAS No. 144, "Accounting for the Impairment or Disposal of Long-lived Assets," (SFAS No. 144). The criteria for determining impairment for such long-lived assets to be held and used is determined by comparing the carrying value of these long-lived assets to management's best estimate of future undiscounted cash flows expected to result from the use of the assets. The Company believes that no impairment existed under SFAS No. 144 as of March 31, 2007 and December 31, 2006. In the event that there are changes in the planned use of the Company's long-lived assets or its expected future undiscounted cash flows are reduced significantly, the Company's assessment of its ability to recover the carrying value of these assets under SFAS No. 144 could change.

(H) STOCK BASED COMPENSATION

On January 1, 2006, we adopted the provisions of SFAS No. 123 (revised 2004), "Share-Based Payment," (SFAS No. 123(R)), which revises SFAS No. 123,"Accounting for Stock-Based Compensation," (SFAS No. 123) and supersedes Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," (APB No. 25).



---

(I) COMPREHENSIVE INCOME

Statement of Financial Accounting Standards (SFAS) No. 130, "Reporting Comprehensive Income," establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, SFAS No. 130 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements.

(J) SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION

Statement of Financial Accounting Standards (SFAS) No. 131, Disclosures about Segments of an Enterprise and Related Information, supersedes SFAS No. 14, "Financial Reporting for Segments of a Business Enterprise. "SFAS No. 131 establishes standards for the way that public companies report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements issued to the public. It also establishes standards for disclosures regarding products and services, geographic areas and major customers. SFAS No. 131 defines operating segments as components of a company about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

NOTE 2-LEASE COMMITMENTS

There are no lease commitments at December 31, 2006. The company entered  into a lease  commitment March 23, 2007.  IFL agreed to lease the terminal from 17617 Aldine Westfield Road, LLC for 18 months at $15,000 per month with an option to purchase the terminal for $3.55 million during the lease term.

NOTE 3-OTHER ASSETS 
NOTES RECEIVABLE

Stuart Sundlun - On November 6, 2003, Mr. Stuart Sundlun acquired 1200 units in Intercontinental Fuels, LLC (IFL) from CMMI. Part of the purchase price was a note from Mr. Sundlun dated November 6, 2003, bearing interest of 10% per annum in the amount of $750,000. This note is secured by 600 units of IFL being held in attorney escrow and released pursuant to the sales agreement. In the event that Mr. Sundlun does not acquire the remaining 600 units in accordance with the sales agreement, the unreleased units will revert to CMMI.







---

NOTE 4 - NOTES PAYABLE

|                                                                                                                              |            
|----------------------------------------------------------------------------------------------------------------------------- | -----------
|Note payable to Stuart Sundlun dated August 7, 2006 bearing interest
    Of 10% per annum, due August 7, 2011.                | 1,598,333  
|Note payable to Capnet Risk no interest bearing due on demand                                                                 | 100,000    
|Note payable to Gulf Coast Fuels no interest bearing interest due on
    demand                                               | 250,000    
|Note payable to Greenway dated bearing interest of 8.5%
Per annum with 24 monthly payments of $4,750, maturing December
2007. | 41,270     
|Total notes payable                                                                                                           | 1,989,603  
|Less current portion                                                                                                          | (489,603)  
|Long term note payable                                                                                                        | $ 1,500,000



NOTE 5 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE

The Company issued Debenture No. 299 in the amount of $ 350,000 on April 15, 2003. The debenture bears interest at the rate of 5% per annum and matured on October 15, 2003.

The Company issued Convertible Debenture No. 300 on April 15, 2003. The debenture bears interest at the rate of 5% per annum and matures on April 15, 2006. The debenture is convertible after April 15, 2004 into $2,000,000 of common stock at a cost per share of seventy percent of the average bid price for the stock for the immediate twenty (20) days before exercise.

These Debentures were cancelled as part of the lawsuit settled March 23, 2007.

NOTE 6 - INCOME TAXES

The Company has net operating loss carry forwards totaling $3,767,644, which expires starting in 2019. These loss carry forwards will offset the income for 2006 and  the first quarter of 2007, consequently there is no provision for income tax. It should be noted that there is a limitation under the Internal Revenue Service Code that could limit the amount of net operating loss carry forward available if there is a change in control of the Company.

NOTE 7 - COMMON AND PREFERRED STOCK

The Company's common stock has a par value of $0.001. There are 50,000,000 shares authorized as of March 31, 2007 and December 31, 2006. As of March 31, 2007 and December 31, 2006 the Company had 44,544,226 and 44,544,226 shares issued and outstanding, respectively.

There were no common stock activities in the first quarter of 2007 or during 2006.

PREFERRED STOCK

In 1998, the Company amended its articles to authorize Preferred Stock. There are 20,000,000 shares authorized with a par value of $0.001. The shares are non-voting and non-redeemable by the Company. The Company further designated two series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with 2,159,193 shares of the total shares authorized and "Series "A" $8.00 Preferred Stock," with the number of authorized shares set at 1,079,957 shares. As of March 31, 2007 and December 31, 2006 there are no shares issued and outstanding.





---

DIVIDENDS

Dividends are non-cumulative, however, the holders of such series, in preference to the holders of any common stock, shall be entitled to receive, as and when declared payable by the Board of Directors from funds legally available for the payment thereof, dividends in lawful money of the United States of America at the rate per annum fixed and determined as herein authorized for the shares of such series, but no more, payable quarterly on the last days of March, June, September, and December in each year with respect tot he quarterly period ending on the day prior to each such respective dividend payment date. In no event shall the holders of either series receive dividends of more than percent (1%) in any fiscal year. Each share of both series shall rank on parity with each other share of preferred stock, irrespective of series, with respect to dividends at the respective fixed or maximum rates for such series.



CONVERSION PROVISIONS

Any holder of either series may convert any or all of such shares into shares of common stock of the Company at any time. Said shares shall be convertible at a rate equal to three (3) shares of common stock of the Company for each one (1) share of Series "A" $12.50 Preferred Stock. The Series "A" 12.50 Preferred Stock shall be convertible, in whole or in part, at any time after the common stock of the Company shall maintain an average bid price per share of at least $12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three (3) shares of common stock of the Company for each one (1) share of Series "A" $8.00 Preferred Stock. The Series "A" $8.00 Preferred Stock shall be convertible, in whole or in part, at any time after the common stock of the Company shall maintain an average bid price per share of at least $8.00 for ten (10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of Preferred Stock in the event of voluntary or involuntary liquidation, dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus the amount of any dividends declared and unpaid thereon.

NOTE 8 - EARNINGS PER SHARE

Earnings per share for the year ended December 31, 2006 is computed as follows:

|                                               |                    |  |                      |  |                 
|---------------------------------------------- | ------------------ |  | -------------------- |  | ----------------
|                                               | Income (Numerator) |  | Shares
(Denominator) |  | Per-Share Amount
|Net income (Loss)                              | 230,786            |  |                      |  |                 
|Basic EPS                                      |                    |  |                      |  |                 
|Income (Loss) available to common stockholders | 230,786            |  | 44,544,226           |  | 0.005           
|Effective Dilutive EPS                         |                    |  |                      |  |                 
|Income (Loss) available to common stockholders | 230,786            |  | 50,000,000*          |  | 0.005           

*As of March 31, 2007, CMMI has 44,544,226 shares outstanding. There are 10,000,000 shares authorized for issuance to Messrs. Byrd and Wooley. CMMI only has 50,000,000 shares authorized in its Articles of Incorporation. It cannot legally issue more shares than the total number authorized by our Articles of Incorporation. Therefore, for purposes of the above calculation, it is assumed that all of CMMIs authorized shares (50,000,000) are outstanding, rather than the full 54,544,226 that are committed. If the full committed amount were used, the Diluted EPS would be 0.004.



NOTE 9  COMMITMENTS AND CONTIGENCIES



None.



NOTE 10  NON-CASH FINANCING TRANSACTIONS



During the first quarter of 2007 and  2006 the Company did not issue stock in exchange for non-cash financing transactions.





---

NOTE 11 - STOCK OPTIONS

The Companys employment agreement with Mr. Byrd provides that he will be paid a salary of $156,000 per year. In 2005, his employment agreement provided for a salary of $96,000. Mr. Wooleys employment agreements for 2005 and 2006 provided for the same compensation. However, during 2005 and 2006, Messrs. Byrds and Wooleys salaries accrued but were not paid due to the Companys severe cash flow problems. Messrs. Byrd and Wooley may require the Company to pay the accrued amounts at any time. In 2006, Messrs. Byrd and Wooley elected to convert part of their accrued salaries into CMMI stock. As a result, the Company agreed to sell Messrs. Byrd and Wooley 5,000,000 shares apiece of common stock at a price of $0.007 per share in December 2006. This stock is not additional compensation to Messrs. Byrd and Wooley; it represents a partial payment of their accrued salaries. Neither Mr. Byrd nor Mr. Wooley purchased any of the shares authorized for issuance to them in 2006. The financials reflect an additional expense of $30,000 for these shares using a market price of $.01 per share.



The Company awarded Ms. Behrens 750,000 shares of restricted stock in 2006. None of these shares have actually been issued to her, however. The Company awarded these shares to Ms. Behrens for her service as a director in 2004, 2005 and 2006. This resulted in an accrued expense of $7,500 for these shares.

NOTE 12 - GOING CONCERN

In prior years, the Companys auditors issued a qualified opinion due to the companies possible inability to continue as a going concern. This was due to past losses and deterioration of its financial condition, as demonstrated by the deficit in working capital, coupled with the lack of operations and being in default on the notes and debentures. In the first quarter of 2007 and the year ended December 31, 2006, the Company generated operating revenue produced by its wholly owned subsidiary. In March of 2007 the Company settled all pending litigation. As part of this settlement, all of the defaulted notes and debentures were cancelled, thereby removing the doubt as to the Companys ability to continue as a going concern.

NOTE 13 - FAIR VALUES

The Company has a number of financial instruments, none of which are held for trading purposes, The Company estimates that the fair value of all financial instruments at March 31, 2007 and December 31, 2006 does not differ materially from the aggregate carrying values of its financial instruments recorded in the accompanying balance sheet.

NOTE 14  LAWSUIT SETTLEMENT



In 2005, a lawsuit was filed putting IFLs ownership of the terminal in question. At the time of these lawsuits, CMMIs note to NARC was in default. The amount outstanding under the note was $725,733. In addition, CMMIs debentures to Dr. Zehr in the principal amount of $2,350,000 plus accrued interest were in default.



On March 23, 2007 the Company settled all litigation with all parties to this transaction. In the settlement, IFL released its claim of ownership of the terminal in favor of NARC. 17617 Aldine Westfield Road, LLC, an entity controlled by Dr. Zehr, then purchased the terminal from NARC for total consideration of $1.55 million ($150,000 in cash and a $1.4 million note). Simultaneously with these transactions, IFL agreed to lease the terminal from 17617 Aldine Westfield Road, LLC for 18 months at $15,000 per month with an option to purchase the terminal for $3.55 million at the end of the lease. In return for the lease, all debentures owed to Dr. Zehr were extinguished.





As a result of these transactions, all claims by and against all parties except Peoples were released. In addition, all lis pendens on IFLs property were released.



ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATIONS.



The following discussion should be read in conjunction with our unaudited consolidated interim financial statements and related notes thereto included in this quarterly report and in our audited consolidated financial statements and Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31, 2006. Certain statements in the following MD&A are forward looking statements. Words such as "expects", "anticipates", "estimates" and similar expressions are intended to identify forward looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.



---



RESULTS OF OPERATIONS



For the quarter ended March 31, 2007, CMMI incurred a net gain of $230,786. For the same period in 2006, our net loss was $(57,000).



However, $659,814 of our income in this quarter was a one-time gain attributable to our settlement of the North American Reserve Corporation lawsuit in March 2007. For more information about this settlement, see Part II, Item 1 of this Form 10-QSB.



We incurred an operating loss of $408,962 for the quarter ended March 31, 2007. This compares to an operating loss of $57,000 for the first quarter of 2006.



In March, the Company brought on two new customers, ORourke Trucking and Ada Resources, Inc., a subsidiary of Adams Resources & Energy, Inc. These two new customers produced revenue for the Company this quarter.



RISK FACTORS



Although the Company is now an operating entity and its financial results have improved greatly, CMII still continues to sustain operating losses due to the accrual of large amounts of consulting fees and legal and professional fees. If these fees continue at their current pace without additional revenue, the Companys performance will be further harmed.



The market price of the Company's common stock has fluctuated significantly since it began to be publicly traded in 1998 and may continue to be highly volatile. Factors such as the ability of the Company to achieve development goals, ability of the Company to compete in the petroleum distribution industry, the ability of the Company to raise additional funds, general market conditions and other factors affecting the Company's business that are beyond the Company's control may cause significant fluctuations in the market price of the Company's common stock. Such market fluctuations could adversely affect the market price for the Company's common stock.



ITEM 3. CONTROLS AND PROCEDURES.



Timothy G. Byrd, Sr., our Chief Executive Officer and Acting Chief Accounting Officer, has concluded that our disclosure controls and procedures are appropriate and effective. He has evaluated these controls and procedures as of a date within 90 days of the filing date of this report on Form 10-QSB.



The Companys internal control over financial reporting has changed in the last fiscal quarter. Specifically, the Company now has a new outsourced accountant who handles the everyday accounting functions of CMMI and its subsidiary, Intercontinental Fuels LLC (IFL).





PART II



ITEM 1. LEGAL PROCEEDINGS



On March 23, 2007, the Company settled a lawsuit to which it was a party.



On March 13, 2006, the Company was sued by Dr. David Zehr. In his lawsuit, Dr. Zehr alleged that CMMI had committed fraud and violations of the Texas Securities Act in connection with the Companys sale of its debentures to him.



Dr. Zehrs suit was a third party crossclaim in a lawsuit which was well underway. Until Dr. Zehrs crossclaim against CMMI, CMMI was not a party to the case. The following describes the genesis of the underlying lawsuit.



In 2005, North American Reserve Corporation (NARC) sued Dr. Zehr, Patrick Palmer, and Jack Peoples based on their personal guarantees of certain promissory notes issued to Wells Fargo Bank, N.A. (Wells Fargo). The guarantees related to Wells Fargos loan to Palm Petroleum and were secured by the land on which IFLs fuel storage terminal is now located. This lawsuit and the other related litigation concerned a joint venture between CMMI and NARC to acquire the terminal that IFL now operates. Several other parties were indirectly involved in this joint venture.



In connection with this joint venture, NARC purchased the Wells Fargo notes, which were then in default. These notes were secured by the land on which the terminal is located. The debtors on these notes were Dr. David Zehr, Patrick Palmer, Jack Peoples, and Palm Petroleum. CMMI loaned part of the money to NARC to purchase the Wells Fargo notes. The money that CMMI loaned to NARC had come from Dr. Zehrs purchase of a CMMI debenture. CMMI then purchased Dr. Zehrs UCC-1liens on the terminals assets and second lien on the land on which the terminal is located in exchange for a second debenture.



After purchasing the notes from Wells Fargo, NARC proceeded to foreclose on the land guaranteeing the notes in 2003. CMMI also foreclosed on the terminals assets securing the liens that it purchased from Dr. Zehr. NARC then sold the land to IFL for $1,025,733 in September 2003 in exchange for a promissory note. CMMI sold its assets to IFL in exchange for a 75% membership interest in IFL and a $1,100,000 promissory note.





---

Two years after NARC had sold the property to IFL, it alleged that a deficiency existed on the Wells Fargo notes. NARC then sued Dr. Zehr, Palmer and Peoples, all of whom had personally guaranteed the notes, in order to recover this deficiency.



Palmer filed a counterclaim against Dr. Zehr for negligent misrepresentation, conspiracy to defraud, and wrongful foreclosure. Dr. Zehr was a director of Palm Petroleum, and as a result, Palmer claimed that Dr. Zehr had conspired with NARC and CMMI to allow them to foreclose on the terminal in breach of Dr. Zehrs fiduciary duty to the company.



Dr. Zehr then crossclaimed against CMMI, alleging fraud and violations of the Texas Securities Act based on CMMIs sale to him of the debentures.



At the time of these lawsuits, IFLs note to NARC was in default. The amount outstanding under the note was $725,733. In addition, CMMI owed Dr. Zehr the principal amount of $2,350,000 plus accrued interest under the debentures. These debentures were also in default at the time of the lawsuits.



One of the main issues in these lawsuits was whether NARC or IFL owned the terminal. NARC claimed that as a result of its foreclosure of the terminal, it owned the entire terminal, including the facilities. CMMI claimed that NARCs foreclosure only vested NARC with ownership of the real property and that all of the above-ground assets (storage tanks and other facilities) belonged to IFL.



On March 23, 2007, the Company settled all litigation with all parties to this transaction. In the settlement, IFL released its claim of ownership of the terminal in favor of NARC. 17617 Aldine Westfield Road, LLC, an entity controlled by Dr. Zehr, then purchased the terminal from NARC for total consideration of $1.55 million ($150,000 in cash and a $1.4 million note). Simultaneously with these transactions, IFL agreed to lease the terminal from 17617 Aldine Westfield Road, LLC for 18 months at $15,000 per month with an option to purchase the terminal for $3.55 million at the end of the lease. In return for the lease, all debentures and other obligations owed to Dr. Zehr were extinguished.



As a result of these transactions, all claims by and against all parties except Peoples were released. In addition, all lis pendens on IFLs property were released.



ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K



EXHIBIT INDEX





EXHIBIT 31.1

Certification of Chief Executive Officer and Acting Chief Accounting Officer pursuant to Rule 15d-14(a) of the Exchange Act



EXHIBIT 32.1

Certification of Chief Executive Officer and Acting Chief Accounting Officer pursuant to 18 U.S.C. Section 1350





SIGNATURES



Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Houston, Texas, on May 18, 2007.



CONSOLIDATED MEDICAL MANAGEMENT, INC.





By:  /s/  Timothy  G.  Byrd,  Sr.

---------------------------------------------

Timothy  G.  Byrd,  Sr.

Chief  Executive  Officer,  Acting Chief Accounting Officer, and Director















---

CERTIFICATION PURSUANT TO RULE 15d-14(a) OF THE EXCHANGE ACT



I, Timothy G. Byrd, Sr., certify that:



1. I have reviewed this quarterly report on Form 10-QSB of Consolidated Medical Management, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of  the end of the period covered by this report

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation

as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.





Date:  May 18, 2007



/s/  Timothy  G.  Byrd, Sr.

----------------------------

Timothy  G.  Byrd, Sr.

Chief  Executive  Officer and Acting

Chief Accounting Officer



---





CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND ACTING CHIEF ACCOUNTING OFFICER OF

CONSOLIDATED MEDICAL MANAGEMENT, INC. PURSUANT TO 18 U.S.C. 1350



I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting Officer of Consolidated Medical Management, Inc. hereby certify that to my knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for the period ended March 31, 2007, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the periodic report on Form 10-QSB and the financial statements contained therein fairly presents, in all material respects, the financial condition and results of the operations of Consolidated Medical Management, Inc.







Date:  May 18, 2007



/s/  Timothy  G.  Byrd, Sr.



----------------------------



Timothy  G.  Byrd,  Sr.,



Chief  Executive  Officer



Consolidated  Medical  Management,  Inc.